Загрузка видео...

Не удалось загрузить видео

Возникла проблема при загрузке этого видео. Это может быть связано с временными проблемами сети или видео может быть недоступно.

На главную

I interviewed Aubrey de Grey on why neither billionaires nor AI will solve aging. And why a single mouse breakthrough could be the ChatGPT moment for longevity. 0:00 - Longevity Field 20 Years On 08:58 - Are Billionaires Getting It Wrong? 17:13 - Bryan Johnson vs Peter Thiel 23:42... show more

Mgoes (bio/acc 🤖💉)

38,020 subscribers

45,429 просмотров • 7 месяцев назад •via X (Twitter)

Здоровье и велнес Наука и технологии

Anya Rossi• Live Now

Private livecam show

Комментарии: 0

Нет доступных комментариев

Здесь появятся комментарии из оригинального поста

Похожие видео

GLP-1s may be the first real human enhancement drug. I interviewed Anant Vinjamoori, MD on why they could be a wedge into longevity, next-gen peptides, programable biology, and AI-driven human upgrades. 0:00 - Health → Human Enhancement? 5:37 - GLP-1s: The Real Novelty 8:23 - Next Gen Drugs, Peptides 13:29 - Un*ucking Regulation 22:50 - Health Influencers & Hype 29:23 - Social Media vs AI Discovery 35:46 - GLP1s = Prozac? 41:35 - Biotech Is The Answer 48:19 - AI Drug Discovery

GLP-1s may be the first real human enhancement drug. I interviewed Anant Vinjamoori, MD on why they could be a wedge into longevity, next-gen peptides, programable biology, and AI-driven human upgrades. 0:00 - Health → Human Enhancement? 5:37 - GLP-1s: The Real Novelty 8:23 - Next Gen Drugs, Peptides 13:29 - Un*ucking Regulation 22:50 - Health Influencers & Hype 29:23 - Social Media vs AI Discovery 35:46 - GLP1s = Prozac? 41:35 - Biotech Is The Answer 48:19 - AI Drug Discovery

Mgoes (bio/acc 🤖💉)

11,396 просмотров • 5 месяцев назад

Sam Altman on God, Elon and the mysterious death of his former employee. (0:00) Is AI Alive? Is It Lying to Us? (3:37) Does Sam Altman Believe in God? (6:37) What Is Morally Right and Wrong According to ChatGPT? (19:08) ChatGPT Users Committing Suicide (27:21) Will Altman Allow ChatGPT for Military Use? (29:01) Altman’s Biggest Fear About AI (31:39) Will AI Bring About Totalitarian Control? (32:48) How Much Privacy Do ChatGPT Users Have? (34:28) The Suspicious Death of Altman’s Former Employee (41:37) Altman’s Thoughts on Elon Musk (43:00) What Jobs Will Be Lost to AI? (47:58) What Are the Downsides of AI? (49:37) Is AI a Religion? (52:31) The Dangers of Deepfakes Includes paid partnerships.

Sam Altman on God, Elon and the mysterious death of his former employee. (0:00) Is AI Alive? Is It Lying to Us? (3:37) Does Sam Altman Believe in God? (6:37) What Is Morally Right and Wrong According to ChatGPT? (19:08) ChatGPT Users Committing Suicide (27:21) Will Altman Allow ChatGPT for Military Use? (29:01) Altman’s Biggest Fear About AI (31:39) Will AI Bring About Totalitarian Control? (32:48) How Much Privacy Do ChatGPT Users Have? (34:28) The Suspicious Death of Altman’s Former Employee (41:37) Altman’s Thoughts on Elon Musk (43:00) What Jobs Will Be Lost to AI? (47:58) What Are the Downsides of AI? (49:37) Is AI a Religion? (52:31) The Dangers of Deepfakes Includes paid partnerships.

Tucker Carlson

12,181,874 просмотров • 11 месяцев назад

Today’s guest on the Free Radicals podcast is Michael Ringel, JD PhD, COO Life Biosciences and former Managing Director at Boston Consulting Group. Michael is a leader in longevity and pharma who spent 25+ years advising top pharma companies on their R&D strategy. He is now COO at Life Biosciences where he is bringing the first ever partial epigenetic reprogramming therapy to human clinical trials - a major milestone for the longevity industry. In this episode, we discuss Michael’s insightful paper on why aging is an optimization by evolution, why that means it’s malleable, and how to push the longevity field forward. Michael also sits on the US board of Hevolution Foundation and on the board of the AFAR. Be sure to follow me and Eric Dai to stay up to date on the latest news in longevity biotech! 0:00 Intro 2:30 Why aging is an optimization by evolution 15:10 Why scientists miss the role of evolution in aging 19:31 Evidence that aging is a regulated process 24:40 Hormesis and adaptive stress responses 28:55 The promise of partial epigenetic reprogramming in humans 35:08 Life Bio's first therapy proceeding to clinical trials 47:47 Why targeting the eye, particularly glaucoma and NION, is a strategic choice 52:03 The pharma industry's perspective on anti-aging research 56:39 The importance of public engagement for funding and policy change 1:05:42 Reasons for optimism in longevity 1:08:26 Advice on how to have an impactful and interdisciplinary career 1:11:54 The ethical case for longevity 1:17:34 Concrete steps for audience members to support longevity research

Today’s guest on the Free Radicals podcast is Michael Ringel, JD PhD, COO Life Biosciences and former Managing Director at Boston Consulting Group. Michael is a leader in longevity and pharma who spent 25+ years advising top pharma companies on their R&D strategy. He is now COO at Life Biosciences where he is bringing the first ever partial epigenetic reprogramming therapy to human clinical trials - a major milestone for the longevity industry. In this episode, we discuss Michael’s insightful paper on why aging is an optimization by evolution, why that means it’s malleable, and how to push the longevity field forward. Michael also sits on the US board of Hevolution Foundation and on the board of the AFAR. Be sure to follow me and Eric Dai to stay up to date on the latest news in longevity biotech! 0:00 Intro 2:30 Why aging is an optimization by evolution 15:10 Why scientists miss the role of evolution in aging 19:31 Evidence that aging is a regulated process 24:40 Hormesis and adaptive stress responses 28:55 The promise of partial epigenetic reprogramming in humans 35:08 Life Bio's first therapy proceeding to clinical trials 47:47 Why targeting the eye, particularly glaucoma and NION, is a strategic choice 52:03 The pharma industry's perspective on anti-aging research 56:39 The importance of public engagement for funding and policy change 1:05:42 Reasons for optimism in longevity 1:08:26 Advice on how to have an impactful and interdisciplinary career 1:11:54 The ethical case for longevity 1:17:34 Concrete steps for audience members to support longevity research

Daniel Shur

16,988 просмотров • 5 месяцев назад

In 2026, it's quite likely that a pill will hit the market which makes dogs live longer. This is a big deal for many reasons. The pill will come from Loyal and Celine Halioua. And they have more therapies in the pipeline. In this episode, we chat about Celine's life and career and Loyal's unique work in the longevity field. The Core Memory podcast - which makes people smarter - is brought to you by the finance wizards at Brex and the genius investors E1 Ventures 🇺🇸. Enjoy! Timestamps 00:00 – Intro 02:47 – Why Start With Dogs 06:05 – Aging Science Explained 09:12 – Inside FDA Trials 13:18 – Designing a Longevity Drug 17:42 – Metabolism and Aging 22:35 – Lessons From Biotech 26:48 – Building Loyal 31:54 – From Neuroscience to Founder 38:19 – GLP-1 vs Longevity Drugs 43:28 – Ethics of Longer Life 49:44 – What Dog Data Shows 54:59 – Longevity Hype & Peptides 59:47 – Biotech Needs Artists 01:05:20 – Investor Hype vs Reality 01:11:35 – AI in Drug Discovery 01:17:49 – Future of Aging Research 01:23:05 – Dogs and the End of Aging

In 2026, it's quite likely that a pill will hit the market which makes dogs live longer. This is a big deal for many reasons. The pill will come from Loyal and Celine Halioua. And they have more therapies in the pipeline. In this episode, we chat about Celine's life and career and Loyal's unique work in the longevity field. The Core Memory podcast - which makes people smarter - is brought to you by the finance wizards at Brex and the genius investors E1 Ventures 🇺🇸. Enjoy! Timestamps 00:00 – Intro 02:47 – Why Start With Dogs 06:05 – Aging Science Explained 09:12 – Inside FDA Trials 13:18 – Designing a Longevity Drug 17:42 – Metabolism and Aging 22:35 – Lessons From Biotech 26:48 – Building Loyal 31:54 – From Neuroscience to Founder 38:19 – GLP-1 vs Longevity Drugs 43:28 – Ethics of Longer Life 49:44 – What Dog Data Shows 54:59 – Longevity Hype & Peptides 59:47 – Biotech Needs Artists 01:05:20 – Investor Hype vs Reality 01:11:35 – AI in Drug Discovery 01:17:49 – Future of Aging Research 01:23:05 – Dogs and the End of Aging

Ashlee Vance

63,172 просмотров • 10 месяцев назад

"Aging is the process of a complex system slowly falling into its chaotic disequilibrium. And it's not like evolution necessarily even set a lifespan for us. It is merely the result of, once the system has been established, how long its intrinsic property stayed ordered before it became disordered." I’m excited to share my conversation with Jacob Kimmel of NewLimit. Every species who has ever lived has one shared certainty: we’ll age, decay, and die. Jacob and his team are among the small group of people on earth with the expertise and funding to work on this problem. We talked about why we age, whether cellular aging can actually be reversed, how evolution shaped our lifespan and our peaks, and how AI is fundamentally changing the next era of science. Recorded at New Limit’s HQ in South San Francisco. Timestamps: 00:00 Intro 01:25 Why Evolution Limits Lifespan 03:13 Evolution Tradeoffs Explained 07:44 Why Women Live Longer 10:15 Lessons from Long Lived Species 16:20 Peak Intelligence 23:26 What is Aging? 27:59 Yamanaka Factors 32:18 New Limit 33:56 AI's Role in Progress 37:28 Organ by Organ Longevity 40:28 Is Immortality Possible? 42:04 Lifespan Progress 45:44 How to Test Longevity Drugs 49:30 Placebo Mind Body Link 53:56 What longevity hacks actually work? 57:25 Peptides And Stem Cells 01:00:34 Gene Editing 01:05:10 Personalized Medicine 01:08:48 Philosophical Dilemmas of Longer Lifespans 01:14:57 Living Off Earth 01:16:55 AI And Bio Risks

"Aging is the process of a complex system slowly falling into its chaotic disequilibrium. And it's not like evolution necessarily even set a lifespan for us. It is merely the result of, once the system has been established, how long its intrinsic property stayed ordered before it became disordered." I’m excited to share my conversation with Jacob Kimmel of NewLimit. Every species who has ever lived has one shared certainty: we’ll age, decay, and die. Jacob and his team are among the small group of people on earth with the expertise and funding to work on this problem. We talked about why we age, whether cellular aging can actually be reversed, how evolution shaped our lifespan and our peaks, and how AI is fundamentally changing the next era of science. Recorded at New Limit’s HQ in South San Francisco. Timestamps: 00:00 Intro 01:25 Why Evolution Limits Lifespan 03:13 Evolution Tradeoffs Explained 07:44 Why Women Live Longer 10:15 Lessons from Long Lived Species 16:20 Peak Intelligence 23:26 What is Aging? 27:59 Yamanaka Factors 32:18 New Limit 33:56 AI's Role in Progress 37:28 Organ by Organ Longevity 40:28 Is Immortality Possible? 42:04 Lifespan Progress 45:44 How to Test Longevity Drugs 49:30 Placebo Mind Body Link 53:56 What longevity hacks actually work? 57:25 Peptides And Stem Cells 01:00:34 Gene Editing 01:05:10 Personalized Medicine 01:08:48 Philosophical Dilemmas of Longer Lifespans 01:14:57 Living Off Earth 01:16:55 AI And Bio Risks

Sabrina Halper

20,755 просмотров • 1 месяц назад

New episode with Dr. Steve Horvath (Prof Steve Horvath), a pioneer in the field of epigenetic aging clocks. Steve developed the original Horvath clock, one of the first tools to show that DNA methylation carries a remarkably reliable signal of aging across human tissues. In this episode, he explains what biological clocks actually measure, why different clocks can disagree, and how to interpret a biological-age result without treating it like a literal lifespan forecast. We talk about chronological age vs. biological age, and we also get into the intervention evidence on exercise and VO2 max, calorie restriction, omega-3s, vitamin D, multivitamins, and weight loss/GLP-1 therapy, among other topics! The big theme is that biological clocks can be useful dashboards, but they are not diagnoses, fortune-telling tools, or proof that one supplement has reversed aging. This was Steve's second appearance on the podcast and he did not disappoint. You won't want to miss this episode. Links to the episode on all platforms in the comments below. Timestamps: 0:00 - Introduction 1:59 - Biological vs. chronological age 7:33 - Why one clock isn't enough 13:16 - PhenoAge vs. GrimAge 15:21 - GrimAge & mortality risk 19:04 - Epigenome as stress memory 23:02 - Can stress be inherited? 25:06 - Why clocks fail in sperm 26:30 - Can lifestyle reverse GrimAge? 28:18 - DunedinPACE as an odometer 32:20 - Judging longevity interventions 34:41 - Clocks as mortality surrogates 38:28 - Most validated interventions 41:25 - 5 years younger in 7 months? 45:43 - Can GrimAge predict death? 47:30 - Translating GrimAge to lifespan 52:16 - Blind spots of aging clocks 58:20 - More than inflammation 1:00:56 - Young blood, transient effects 1:04:46 - Calorie restriction 1:08:54 - GLP-1 drugs & weight loss 1:12:24 - Can a multivitamin slow aging? 1:21:05 - Omega-3, vitamin D, & exercise 1:28:55 - Removing an aging accelerator 1:31:24 - Vegetables vs. exercise 1:36:58 - Does red meat age you? 1:38:38 - Hard training moves the clock 1:45:59 - Heat as an exercise mimetic 1:47:23 - When cold slows the clock 1:49:48 - Does poor sleep speed aging? 1:51:19 - Can friendship slow aging? 1:57:49 - Are consumer tests worth it? 2:02:46 - Choosing a reliable test 2:07:33 - Different clocks, different lenses 2:12:21 - Can AI build better clocks? 2:13:53 - Partial reprogramming 2:17:47 - What reprogramming can't fix 2:22:37 - Do DNA mutations drive aging? 2:24:53 - The silver bullet problem 2:29:23 - Limits of polygenic risk 2:33:32 - Steve's longevity routine 2:38:05 - How stress affects aging

New episode with Dr. Steve Horvath (Prof Steve Horvath), a pioneer in the field of epigenetic aging clocks. Steve developed the original Horvath clock, one of the first tools to show that DNA methylation carries a remarkably reliable signal of aging across human tissues. In this episode, he explains what biological clocks actually measure, why different clocks can disagree, and how to interpret a biological-age result without treating it like a literal lifespan forecast. We talk about chronological age vs. biological age, and we also get into the intervention evidence on exercise and VO2 max, calorie restriction, omega-3s, vitamin D, multivitamins, and weight loss/GLP-1 therapy, among other topics! The big theme is that biological clocks can be useful dashboards, but they are not diagnoses, fortune-telling tools, or proof that one supplement has reversed aging. This was Steve's second appearance on the podcast and he did not disappoint. You won't want to miss this episode. Links to the episode on all platforms in the comments below. Timestamps: 0:00 - Introduction 1:59 - Biological vs. chronological age 7:33 - Why one clock isn't enough 13:16 - PhenoAge vs. GrimAge 15:21 - GrimAge & mortality risk 19:04 - Epigenome as stress memory 23:02 - Can stress be inherited? 25:06 - Why clocks fail in sperm 26:30 - Can lifestyle reverse GrimAge? 28:18 - DunedinPACE as an odometer 32:20 - Judging longevity interventions 34:41 - Clocks as mortality surrogates 38:28 - Most validated interventions 41:25 - 5 years younger in 7 months? 45:43 - Can GrimAge predict death? 47:30 - Translating GrimAge to lifespan 52:16 - Blind spots of aging clocks 58:20 - More than inflammation 1:00:56 - Young blood, transient effects 1:04:46 - Calorie restriction 1:08:54 - GLP-1 drugs & weight loss 1:12:24 - Can a multivitamin slow aging? 1:21:05 - Omega-3, vitamin D, & exercise 1:28:55 - Removing an aging accelerator 1:31:24 - Vegetables vs. exercise 1:36:58 - Does red meat age you? 1:38:38 - Hard training moves the clock 1:45:59 - Heat as an exercise mimetic 1:47:23 - When cold slows the clock 1:49:48 - Does poor sleep speed aging? 1:51:19 - Can friendship slow aging? 1:57:49 - Are consumer tests worth it? 2:02:46 - Choosing a reliable test 2:07:33 - Different clocks, different lenses 2:12:21 - Can AI build better clocks? 2:13:53 - Partial reprogramming 2:17:47 - What reprogramming can't fix 2:22:37 - Do DNA mutations drive aging? 2:24:53 - The silver bullet problem 2:29:23 - Limits of polygenic risk 2:33:32 - Steve's longevity routine 2:38:05 - How stress affects aging

Dr. Rhonda Patrick

87,348 просмотров • 2 месяцев назад

E182: Jordi Visser - Why Aging is a disease, Why Bitcoin is a hedge against abundance and why you shouldn't buy a house! Jordi Visser spent three decades on Wall Street, from a Morgan Stanley trading desk to CIO at Weiss Multi-Strategy. These days he studies AI, macro, and longevity full time. We cover why he thinks aging is optional, why Bitcoin is the only asset he'd bet on for the next decade, and why money never actually made him happy. 00:00 Intro 02:10 Jordi's Weekend Recap 03:49 The Blueprint For Living To 100 04:31 Why Longevity Became An Obsession 05:44 What Kills A Healthy Habit 07:20 Supplements & Meds: Worth It? 09:51 Partnerships: Variational Bitwise 10:44 The First Step Into Longevity 12:17 Wealth's Hidden Effect On Longevity 14:03 Peptides & Hormones: Jordi's Take 17:47 What Is Heart-Rate Variability? 21:21 How To Track Your HRV 23:17 Average vs. Great HRV 25:12 Lessons From The Finance World 29:10 Learning What Money Really Means 31:58 Partnership: KAST 32:47 Why Make More Money At All 35:20 "AI Will Make Everything Abundant" 38:20 Does Abundance Mean Cheaper? 38:54 Why We'll Still Need Wealth 41:22 How Jordi Fell Into Bitcoin 47:44 Jordi's Bitcoin Thesis, Simplified 50:10 How Much Bitcoin Is In His Portfolio 50:48 Would Jordi Ever Sell? 51:52 Partnerships: Jupiter Ethena 52:38 How Big Can Bitcoin Get 54:00 On "Bitcoin Is Too Expensive" 55:28 Why A Crypto Channel, Not Just Bitcoin 56:25 Does Jordi Own Other Crypto 57:24 Other Scarce Assets He's Bought 58:41 Should 20-Somethings Buy A House 01:02:00 Routine vs. Unique 01:03:57 Why Allergies Aren't Real 01:07:02 Closing Thoughts

E182: Jordi Visser - Why Aging is a disease, Why Bitcoin is a hedge against abundance and why you shouldn't buy a house! Jordi Visser spent three decades on Wall Street, from a Morgan Stanley trading desk to CIO at Weiss Multi-Strategy. These days he studies AI, macro, and longevity full time. We cover why he thinks aging is optional, why Bitcoin is the only asset he'd bet on for the next decade, and why money never actually made him happy. 00:00 Intro 02:10 Jordi's Weekend Recap 03:49 The Blueprint For Living To 100 04:31 Why Longevity Became An Obsession 05:44 What Kills A Healthy Habit 07:20 Supplements & Meds: Worth It? 09:51 Partnerships: Variational Bitwise 10:44 The First Step Into Longevity 12:17 Wealth's Hidden Effect On Longevity 14:03 Peptides & Hormones: Jordi's Take 17:47 What Is Heart-Rate Variability? 21:21 How To Track Your HRV 23:17 Average vs. Great HRV 25:12 Lessons From The Finance World 29:10 Learning What Money Really Means 31:58 Partnership: KAST 32:47 Why Make More Money At All 35:20 "AI Will Make Everything Abundant" 38:20 Does Abundance Mean Cheaper? 38:54 Why We'll Still Need Wealth 41:22 How Jordi Fell Into Bitcoin 47:44 Jordi's Bitcoin Thesis, Simplified 50:10 How Much Bitcoin Is In His Portfolio 50:48 Would Jordi Ever Sell? 51:52 Partnerships: Jupiter Ethena 52:38 How Big Can Bitcoin Get 54:00 On "Bitcoin Is Too Expensive" 55:28 Why A Crypto Channel, Not Just Bitcoin 56:25 Does Jordi Own Other Crypto 57:24 Other Scarce Assets He's Bought 58:41 Should 20-Somethings Buy A House 01:02:00 Routine vs. Unique 01:03:57 Why Allergies Aren't Real 01:07:02 Closing Thoughts

MR SHIFT 🦁

126,940 просмотров • 15 дней назад

I recently sat down with João Filipe and revealed my exact plan to build a $100M AI company. This is more than I've ever revealed publicly before. 0:00 Trailer 2:34 Credentials 5:56 Running multiple companies at once 11:45 Why I love content 13:33 My background 20:11 Don't quit your job *yet* 25:24 Opportunity cost 31:39 Self-reflection 36:07 Owning your AI memory 39:02 Using AI for content 52:22 Audit your life 55:39 The one AI system everyone should build 58:07 Traits > Skills 58:47 Founding AI Edge 1:01:00 How to spot trends early 1:14:00 Reinvesting in AI Edge 1:20:01 Spending $100k +/mo on AI 1:32:02 𝕏 vs. YouTube 1:49:32 My take on "AI influencers" 1:50:29 Biggest takeaway from the podcast 1:53:49 Health is the best investment

I recently sat down with João Filipe and revealed my exact plan to build a $100M AI company. This is more than I've ever revealed publicly before. 0:00 Trailer 2:34 Credentials 5:56 Running multiple companies at once 11:45 Why I love content 13:33 My background 20:11 Don't quit your job yet 25:24 Opportunity cost 31:39 Self-reflection 36:07 Owning your AI memory 39:02 Using AI for content 52:22 Audit your life 55:39 The one AI system everyone should build 58:07 Traits > Skills 58:47 Founding AI Edge 1:01:00 How to spot trends early 1:14:00 Reinvesting in AI Edge 1:20:01 Spending $100k +/mo on AI 1:32:02 𝕏 vs. YouTube 1:49:32 My take on "AI influencers" 1:50:29 Biggest takeaway from the podcast 1:53:49 Health is the best investment

Miles Deutscher

57,336 просмотров • 1 месяц назад

AI will be safer than human doctors this year. I spoke to Superpower founder Max Marchione on why health is an information problem a human brain can't solve, and why half of humanity will be on a daily peptide within 10 years. 00:00 - Health Post AGI 04:04 - Healthcare Is Broken 07:14 - Execution Is The Moat 10:29 - The Tesla of Healthcare 14:23 - AI Caught a Stroke 19:45 - Apple vs OpenAI 23:23 - AI Doctors = Driverless Cars 26:02 - Truth-Seeking Medical AI 30:26 - Are Biomarkers Irrelevant? 33:37 - Doctors Can’t Think 36:18 - Peptides for All 40:19 - What Are You On?

AI will be safer than human doctors this year. I spoke to Superpower founder Max Marchione on why health is an information problem a human brain can't solve, and why half of humanity will be on a daily peptide within 10 years. 00:00 - Health Post AGI 04:04 - Healthcare Is Broken 07:14 - Execution Is The Moat 10:29 - The Tesla of Healthcare 14:23 - AI Caught a Stroke 19:45 - Apple vs OpenAI 23:23 - AI Doctors = Driverless Cars 26:02 - Truth-Seeking Medical AI 30:26 - Are Biomarkers Irrelevant? 33:37 - Doctors Can’t Think 36:18 - Peptides for All 40:19 - What Are You On?

Mgoes (bio/acc 🤖💉)

41,076 просмотров • 16 дней назад

🎙️ New The Edge Podcast ⚔️ Wartime Ethereum: The Case For ETH Going Much Higher 0:00 - Intro 3:01 - John's background 8:39 - Why focus on Ethereum and ETH 14:29 - Why Wartime Ethereum mode? 17:44 - Ethereum can’t be evil 20:23 - Trustware for economic systems 24:48 - Is Wall Street understanding ETH's value? 32:04 - Institutional bull run vs bearish retail 36:03 - When will ETH go up? 45:57 - CLARITY Act tailwind for Ethereum 52:11 - No EF funding crisis, just eco reshaping 59:05 - Decentralized AI makes case for Ethereum 1:08:39 - Questioning the rules of the system 1:10:33 - How to value ETH 1:14:29 - John's outlook for ETH price 1:18:23 - Closing 🙏 Thanks to John Gillen - WartimeEthereum.eth from Milk Road for joining us!

🎙️ New The Edge Podcast ⚔️ Wartime Ethereum: The Case For ETH Going Much Higher 0:00 - Intro 3:01 - John's background 8:39 - Why focus on Ethereum and ETH 14:29 - Why Wartime Ethereum mode? 17:44 - Ethereum can’t be evil 20:23 - Trustware for economic systems 24:48 - Is Wall Street understanding ETH's value? 32:04 - Institutional bull run vs bearish retail 36:03 - When will ETH go up? 45:57 - CLARITY Act tailwind for Ethereum 52:11 - No EF funding crisis, just eco reshaping 59:05 - Decentralized AI makes case for Ethereum 1:08:39 - Questioning the rules of the system 1:10:33 - How to value ETH 1:14:29 - John's outlook for ETH price 1:18:23 - Closing 🙏 Thanks to John Gillen - WartimeEthereum.eth from Milk Road for joining us!

DeFi Dad ⟠ defidad.eth

39,765 просмотров • 1 месяц назад

My latest conversation with the always incredible Benedict Evans: OpenAI’s moat problem, the rise of ephemeral and improvised sofware, OpenClaw & agents. 00:00 Intro 01:06 OpenAI's Focus Shift 03:12 ChatGPT usage: a "mile wide, inch deep" 09:03 Why better models do not solve the real problem 13:58 Why AI product teams are strategy takers, not strategy setters 15:38 Do agents help create defensibility? 20:06 OpenClaw and the "Desktop Linux" moment for AI 25:52 Why "everyone will build their own software" is completely wrong 28:09 Improvised software vs. institutionalized software 29:23 Why there will be more software, not less 36:15 Are we heading toward value destruction before value creation? 38:03 Circular revenue, leverage, and AI bubble dynamics 38:53 Big Tech's Trillion-Dollar CapEx Crisis & Financial Gravity 45:23 Why AI job exposure charts can be misleading 52:15 How Fortune 500 Execs are actually deploying AI today 56:45 The White Space: What this means for founders and investors

My latest conversation with the always incredible Benedict Evans: OpenAI’s moat problem, the rise of ephemeral and improvised sofware, OpenClaw & agents. 00:00 Intro 01:06 OpenAI's Focus Shift 03:12 ChatGPT usage: a "mile wide, inch deep" 09:03 Why better models do not solve the real problem 13:58 Why AI product teams are strategy takers, not strategy setters 15:38 Do agents help create defensibility? 20:06 OpenClaw and the "Desktop Linux" moment for AI 25:52 Why "everyone will build their own software" is completely wrong 28:09 Improvised software vs. institutionalized software 29:23 Why there will be more software, not less 36:15 Are we heading toward value destruction before value creation? 38:03 Circular revenue, leverage, and AI bubble dynamics 38:53 Big Tech's Trillion-Dollar CapEx Crisis & Financial Gravity 45:23 Why AI job exposure charts can be misleading 52:15 How Fortune 500 Execs are actually deploying AI today 56:45 The White Space: What this means for founders and investors

Matt Turck

36,594 просмотров • 5 месяцев назад

E97: Gavin Wood : Why Ethereum is Going Nowhere since 8 years (and my solution to it) Dr. Gavin Wood is the CoFounder of Ethereum, the Creator of the EVM and of the solidity language, and the Inventor and Founder of Polkadot & Parity Technologies Timestamps 0:00 Introduction 2:44 Culture in Japan VS UK 6:00 Humour 7:40 Who is Gavin? 9:17 Mission 10:28 Characteristics of Successful Founders 13:53 Developing Big Ideas 16:08 Creative Success Mechanism 20:03 Suffering 24:56 From Theory to Transactions 32:28 Building a Support Network 34:36 Legacy Banking Systems 36:01 Music Engineering 45:08 Childhood Dreams 46:27 Camino de Santiago 49:19 Crypto Fascination 54:44 Web3: The Post Snowden Web 1:00:39 Co-Founding Ethereum 1:03:12 Biggest Ethereum Achievement 1:04:04 Is Ethereum a Success? 1:07:38 Why Gavin Left Ethereum 1:09:48 Polkadot 1:14:53 Polkadots Achievements and Problems 1:24:05 Solution to Polkadot Main Problem 1:28:12 Polkadots Adoption & Communication Strategy 1:38:26 Polkadot Vision of Success 1:42:30 Memecoins 1:45:19 Crypto Integrity 1:49:45 Crypto's Limited Adoption 1:58:35 Identity vs. Individuality 2:07:15 Is AI a Bad Thing? 2:09:27 AI's Communication Revolution 2:25:06 Decentralization Role in AI 2:29:08 Eternal Happiness 2:32:17 Are You Happy? 2:33:52 Meaning of Life 2:38:58 What is Money? 2:45:55 Experience as a Father 2:48:54 Non-Consensus Beliefs

E97: Gavin Wood : Why Ethereum is Going Nowhere since 8 years (and my solution to it) Dr. Gavin Wood is the CoFounder of Ethereum, the Creator of the EVM and of the solidity language, and the Inventor and Founder of Polkadot & Parity Technologies Timestamps 0:00 Introduction 2:44 Culture in Japan VS UK 6:00 Humour 7:40 Who is Gavin? 9:17 Mission 10:28 Characteristics of Successful Founders 13:53 Developing Big Ideas 16:08 Creative Success Mechanism 20:03 Suffering 24:56 From Theory to Transactions 32:28 Building a Support Network 34:36 Legacy Banking Systems 36:01 Music Engineering 45:08 Childhood Dreams 46:27 Camino de Santiago 49:19 Crypto Fascination 54:44 Web3: The Post Snowden Web 1:00:39 Co-Founding Ethereum 1:03:12 Biggest Ethereum Achievement 1:04:04 Is Ethereum a Success? 1:07:38 Why Gavin Left Ethereum 1:09:48 Polkadot 1:14:53 Polkadots Achievements and Problems 1:24:05 Solution to Polkadot Main Problem 1:28:12 Polkadots Adoption & Communication Strategy 1:38:26 Polkadot Vision of Success 1:42:30 Memecoins 1:45:19 Crypto Integrity 1:49:45 Crypto's Limited Adoption 1:58:35 Identity vs. Individuality 2:07:15 Is AI a Bad Thing? 2:09:27 AI's Communication Revolution 2:25:06 Decentralization Role in AI 2:29:08 Eternal Happiness 2:32:17 Are You Happy? 2:33:52 Meaning of Life 2:38:58 What is Money? 2:45:55 Experience as a Father 2:48:54 Non-Consensus Beliefs

MR SHIFT 🦁

265,222 просмотров • 1 год назад

NEW POD | EP 72 How Long Will This Bear Market Last? qw & Imran Timestamps: 0:56 State of the Market 3:23 Is Anyone Bullish? 4:08 Tariffs & the Economy 10:09 Crypto Sentiment Divergence 13:18 Ethena and Ondo Launching Their Own Layer 1 15:55 Regulation and Counterparty Risk 18:28 Tokenizing $COIN on Base 19:49 Stablecoins 20:41 Robinhood & Kalshi 22:12 State of AI 22:25 Manus AI 26:02 China vs. US AI Video Models 28:55 Localized LLMs & Privacy 29:44 Apple Intelligence & Privacy Issues 32:02 Using Localized LLMs 32:51 Global Paranoia About Privacy 34:14 Vibe Coding 39:53 Tokenizing Startups and Equity 42:49 BYD's New 1,000kw EV Charging Technology 45:42 Robotics 49:48 Crypto and Robotics 53:23 AI and Robotics in the Workforce 54:26 Where are we headed? Link ↓

NEW POD | EP 72 How Long Will This Bear Market Last? qw & Imran Timestamps: 0:56 State of the Market 3:23 Is Anyone Bullish? 4:08 Tariffs & the Economy 10:09 Crypto Sentiment Divergence 13:18 Ethena and Ondo Launching Their Own Layer 1 15:55 Regulation and Counterparty Risk 18:28 Tokenizing $COIN on Base 19:49 Stablecoins 20:41 Robinhood & Kalshi 22:12 State of AI 22:25 Manus AI 26:02 China vs. US AI Video Models 28:55 Localized LLMs & Privacy 29:44 Apple Intelligence & Privacy Issues 32:02 Using Localized LLMs 32:51 Global Paranoia About Privacy 34:14 Vibe Coding 39:53 Tokenizing Startups and Equity 42:49 BYD's New 1,000kw EV Charging Technology 45:42 Robotics 49:48 Crypto and Robotics 53:23 AI and Robotics in the Workforce 54:26 Where are we headed? Link ↓

Good Game

12,078 просмотров • 1 год назад

The Sam Altman Interview You know him as the CEO of OpenAI — but he's also an avid writer. We spoke not once but twice about how Sam captures ideas, clarifies his thinking, edits his writing, decides what to work on, and uses ChatGPT. Timestamps: 1:47 Will LLMs change how we write? 8:39 How does Sam use ChatGPT? 11:26 How Sam became less anxious 17:24 Sam once dreamed of being a novelist 18:37 Lessons from Peter Thiel 21:35 Lessons from Paul Graham 26:02 The book Sam Altman wants to write 28:37 Advice for startup founders 30:20 How Y Combinator shapes OpenAI 35:55 How Sam chose to work on AGI 37:35 Writing strategy memos at OpenAI 41:34 Why isn’t ChatGPT a better storyteller? 44:20 Sam's obsessive note-taking method 47:12 Will AI put writers out of work?

The Sam Altman Interview You know him as the CEO of OpenAI — but he's also an avid writer. We spoke not once but twice about how Sam captures ideas, clarifies his thinking, edits his writing, decides what to work on, and uses ChatGPT. Timestamps: 1:47 Will LLMs change how we write? 8:39 How does Sam use ChatGPT? 11:26 How Sam became less anxious 17:24 Sam once dreamed of being a novelist 18:37 Lessons from Peter Thiel 21:35 Lessons from Paul Graham 26:02 The book Sam Altman wants to write 28:37 Advice for startup founders 30:20 How Y Combinator shapes OpenAI 35:55 How Sam chose to work on AGI 37:35 Writing strategy memos at OpenAI 41:34 Why isn’t ChatGPT a better storyteller? 44:20 Sam's obsessive note-taking method 47:12 Will AI put writers out of work?

David Perell

239,789 просмотров • 1 год назад

Today I am launching the Free Radicals podcast with Eric Dai . Every Tuesday, we’ll be releasing long form conversations with the visionaries giving humanity control over biology and working to dramatically extend human lifespan. We’re thrilled to host Celine Halioua, Founder + CEO Loyal, for our inaugural episode. Celine is building the world’s first lifespan extension drugs for dogs. Follow me, Eric Dai and Free Radicals for new episodes every Tuesday. 00:00:00 - Intro 00:01:51 - Celine’s background 00:05:00 - Dropping out of academia 00:07:50 - Finding ways to increase free will 00:09:36 - How to align financial incentives with longevity 00:14:52 - Longevity drugs should be boring 00:21:24 - Celine’s leadership style 00:24:08 - Advice on fundraising and constructing feedback loops 00:26:52 - Loyal’s fundraising history 00:27:57 - Building for Zero Billion Dollar Markets 00:29:11 - How to succeed in biotech 00:30:21 - How to find blockbuster opportunities 00:33:25 - How to create a gold rush in longevity 00:35:25 - The problem with the aging field 00:39:32 - How to identify signal from noise 00:41:54 - AI applications to biology 00:45:15 - Importance of naiveté 00:47:24 - FREE RADICALS

Today I am launching the Free Radicals podcast with Eric Dai . Every Tuesday, we’ll be releasing long form conversations with the visionaries giving humanity control over biology and working to dramatically extend human lifespan. We’re thrilled to host Celine Halioua, Founder + CEO Loyal, for our inaugural episode. Celine is building the world’s first lifespan extension drugs for dogs. Follow me, Eric Dai and Free Radicals for new episodes every Tuesday. 00:00:00 - Intro 00:01:51 - Celine’s background 00:05:00 - Dropping out of academia 00:07:50 - Finding ways to increase free will 00:09:36 - How to align financial incentives with longevity 00:14:52 - Longevity drugs should be boring 00:21:24 - Celine’s leadership style 00:24:08 - Advice on fundraising and constructing feedback loops 00:26:52 - Loyal’s fundraising history 00:27:57 - Building for Zero Billion Dollar Markets 00:29:11 - How to succeed in biotech 00:30:21 - How to find blockbuster opportunities 00:33:25 - How to create a gold rush in longevity 00:35:25 - The problem with the aging field 00:39:32 - How to identify signal from noise 00:41:54 - AI applications to biology 00:45:15 - Importance of naiveté 00:47:24 - FREE RADICALS

Daniel Shur

29,517 просмотров • 9 месяцев назад

A deep dive conversation with Dan Shipper 📧 on how AI can (actually) improve your life. We explore the human side of AI: why producing good work still requires taste, how coordinating agents can fry your attention and why automation actually creates more work for humans. Timestamps: 0:38 Annie Dillard, art + writing 4:14 Can AI deepen human craft? 5:43 The slot-machine effect of AI agents 6:55 Dan's “house phone” experiment 8:01 What AI can actually help us create 13:55 AI as a non-specific amplifier 17:23 Why AI companies mishandled the story 19:36 Will AI destroy jobs? 22:35 AI as “frozen competence” 26:11 Are human-AI centaurs temporary? 31:34 Career advice for the AI era 37:19 The skills that matter now 40:08 Every 🪨 as an AI research lab 42:25 The coherence problem 45:25 Rapid-fire questions 48:00 Super-intelligence by 2030? 50:44 Life after superintelligence 52:07 The questions Dan is living 53:02 Give yourself permission

A deep dive conversation with Dan Shipper 📧 on how AI can (actually) improve your life. We explore the human side of AI: why producing good work still requires taste, how coordinating agents can fry your attention and why automation actually creates more work for humans. Timestamps: 0:38 Annie Dillard, art + writing 4:14 Can AI deepen human craft? 5:43 The slot-machine effect of AI agents 6:55 Dan's “house phone” experiment 8:01 What AI can actually help us create 13:55 AI as a non-specific amplifier 17:23 Why AI companies mishandled the story 19:36 Will AI destroy jobs? 22:35 AI as “frozen competence” 26:11 Are human-AI centaurs temporary? 31:34 Career advice for the AI era 37:19 The skills that matter now 40:08 Every 🪨 as an AI research lab 42:25 The coherence problem 45:25 Rapid-fire questions 48:00 Super-intelligence by 2030? 50:44 Life after superintelligence 52:07 The questions Dan is living 53:02 Give yourself permission

Jonny Miller

94,051 просмотров • 25 дней назад

New Limit just raised $435 million. This is, in part, because they've had a massive breakthrough on reversing the age of the liver with their new brand of genetic reprogramming drugs. For the first time, NewLimit's co-founder and president Jacob Kimmel details the company's breakthrough here. We also get into the longevity and bio-tech fields more broadly to explain where aging science and AI are heading. If nothing else, come to see some mice get drunk. The Core Memory podcast is available wherever you pod, and I'll put the YouTube link down below in the replies. Our show is sponsored by Brex and SendCutSend. They are both wise and benevolent. Timestamps 0:00 Intro 3:50 What Is Epigenetic Reprogramming? 7:16 Growing a Whole Animal From One Old Cell 13:06 Meet Ambrosia, the AI Hunting for Youth 22:44 $435 Million and the Race to Human Trials 29:26 The Drunk Mice That Skip the Hangover 36:48 Inside the First Human Trial 43:14 Will There Ever Be a Hangover Pen? 49:39 Beyond the Liver: The Delivery Problem 1:03:27 Answering the Skeptics 1:12:42 Will OpenAI Become a Drug Company? 1:23:53 The Health Story Bigger Than AI? 1:35:00 How Far Behind Is the US vs China? 1:53:10 Can We Build Computers From Neurons?

Ashlee Vance

93,172 просмотров • 2 месяцев назад

My dear friend, Vlad Tenev, changed the landscape of investing forever! The rise of the retail investor is largely due to Robinhood's success... and in this new Journey Man, we discuss it all... Enjoy! 00:00 - Intro 00:53 - Introducing Vlad Tenev of Robinhood 01:27 - Why Take on Wall Street? 01:54 - Robinhood’s Zero-Fee Origin Story 02:53 - Inspiration from Instagram and Uber 04:24 - Reimagining Trading for Mobile 05:05 - The Challenge of Disrupting Finance 05:42 - Why Everything Is Hard 06:34 - Early Wrong Assumptions 07:42 - Raising Capital with a Small Vision 08:48 - Funding Robinhood on AngelList 09:50 - Early Investors Changed Their Lives 10:38 - The Crypto Explosion Begins 11:07 - Considering a Bitcoin Exchange First 12:17 - Bitcoin’s Early Skepticism and Growth 13:08 - Robinhood Launches Crypto in 2018 14:03 - 2020: Crypto Revenue Surges Overnight 15:04 - The Challenge of Crypto Cyclicality 16:11 - Staffing a Volatile Business 17:10 - Building Robinhood’s Lean Crypto Team 18:46 - Robinhood’s First Crypto Event Coming 19:38 - Where TradFi Meets DeFi 20:34 - Tokenizing Everything 21:09 - Robinhood’s Vision for Crypto + Finance 21:47 - Thoughts on Crypto Options Demand 23:04 - Why Crypto Options Haven’t Taken Off 24:09 - Millennials and the Speculative Economy 25:22 - Democratizing Trading for Everyone 26:08 - Why Buy-and-Hold Doesn’t Work for All 27:15 - Trading vs Investing: A Matter of Wealth 28:01 - Trading as a Skill Anyone Can Build 29:13 - Robinhood’s Role in Onboarding Millions 30:06 - The Fed's Role and Retail Insight 31:03 - The Rise of the Retail Macro Trader 32:17 - Helping Users Succeed with Robinhood Strategies 33:35 - Power of Community and the Hive Mind 34:55 - Will AI Disrupt Community Too? 36:14 - Technological Waves and Investor Opportunity 37:10 - Human Purpose in an AI World 37:52 - Tokenizing Human Connection 38:28 - Creators, Platforms, and Future-Proofing 39:26 - Vlad’s Long-Term View of the Future 40:05 - Financial Services at the Heart of Disruption 41:14 - If AI Replaces Jobs, What Happens to Investing? 42:25 - Entering the Economic Singularity 43:31 - What Happens When AIs Win the Markets? 44:16 - AI's Role in Capital and Markets 45:07 - Will AI Eliminate Human Emotion from Markets? 46:06 - HFT: The Original AI Traders 47:20 - AI and Long-Term Probabilistic Forecasting 48:48 - GPUs, Gaming, and the Origins of AI 50:01 - Nvidia, CUDA, and Wall Street Arms Races 51:04 - Flash Boys and Microwave Trading 51:54 - Will AI Costs Go to Zero? 52:52 - Lower Cost, Higher Usage 53:41 - Robinhood’s UX Won’t Be Just a Chatbox 55:16 - Cortex: AI-Powered Features at Robinhood 56:54 - Tokenization and the Future of Asset Management 57:44 - Crowdsourced, Tokenized Hedge Funds 58:48 - Portability of Tokenized Assets 59:39 - Blockchain as the New Rails of Finance 01:00:09 - The Trump Token and Capital Formation 01:01:00 - Capital Access Unlocks Innovation 01:01:49 - Why Crypto Needs Regulatory Clarity 01:03:17 - From Meme Coins to Real Assets 01:04:17 - Crypto's Path to $100 Trillion? 01:05:15 - The Financial System Will Run on Blockchains 01:06:00 - Platform Layer vs Application Layer Wealth 01:06:29 - AI Raises Money and Launches Tokens 01:07:39 - AIs Creating Software and Capital Formation 01:08:00 - Final Thoughts: A Wild Future Ahead 01:08:20 - When Will Vlad Buy a CryptoPunk? 01:08:51 - Wrapping Up: AI, Crypto, and the Road Ahead

My dear friend, Vlad Tenev, changed the landscape of investing forever! The rise of the retail investor is largely due to Robinhood's success... and in this new Journey Man, we discuss it all... Enjoy! 00:00 - Intro 00:53 - Introducing Vlad Tenev of Robinhood 01:27 - Why Take on Wall Street? 01:54 - Robinhood’s Zero-Fee Origin Story 02:53 - Inspiration from Instagram and Uber 04:24 - Reimagining Trading for Mobile 05:05 - The Challenge of Disrupting Finance 05:42 - Why Everything Is Hard 06:34 - Early Wrong Assumptions 07:42 - Raising Capital with a Small Vision 08:48 - Funding Robinhood on AngelList 09:50 - Early Investors Changed Their Lives 10:38 - The Crypto Explosion Begins 11:07 - Considering a Bitcoin Exchange First 12:17 - Bitcoin’s Early Skepticism and Growth 13:08 - Robinhood Launches Crypto in 2018 14:03 - 2020: Crypto Revenue Surges Overnight 15:04 - The Challenge of Crypto Cyclicality 16:11 - Staffing a Volatile Business 17:10 - Building Robinhood’s Lean Crypto Team 18:46 - Robinhood’s First Crypto Event Coming 19:38 - Where TradFi Meets DeFi 20:34 - Tokenizing Everything 21:09 - Robinhood’s Vision for Crypto + Finance 21:47 - Thoughts on Crypto Options Demand 23:04 - Why Crypto Options Haven’t Taken Off 24:09 - Millennials and the Speculative Economy 25:22 - Democratizing Trading for Everyone 26:08 - Why Buy-and-Hold Doesn’t Work for All 27:15 - Trading vs Investing: A Matter of Wealth 28:01 - Trading as a Skill Anyone Can Build 29:13 - Robinhood’s Role in Onboarding Millions 30:06 - The Fed's Role and Retail Insight 31:03 - The Rise of the Retail Macro Trader 32:17 - Helping Users Succeed with Robinhood Strategies 33:35 - Power of Community and the Hive Mind 34:55 - Will AI Disrupt Community Too? 36:14 - Technological Waves and Investor Opportunity 37:10 - Human Purpose in an AI World 37:52 - Tokenizing Human Connection 38:28 - Creators, Platforms, and Future-Proofing 39:26 - Vlad’s Long-Term View of the Future 40:05 - Financial Services at the Heart of Disruption 41:14 - If AI Replaces Jobs, What Happens to Investing? 42:25 - Entering the Economic Singularity 43:31 - What Happens When AIs Win the Markets? 44:16 - AI's Role in Capital and Markets 45:07 - Will AI Eliminate Human Emotion from Markets? 46:06 - HFT: The Original AI Traders 47:20 - AI and Long-Term Probabilistic Forecasting 48:48 - GPUs, Gaming, and the Origins of AI 50:01 - Nvidia, CUDA, and Wall Street Arms Races 51:04 - Flash Boys and Microwave Trading 51:54 - Will AI Costs Go to Zero? 52:52 - Lower Cost, Higher Usage 53:41 - Robinhood’s UX Won’t Be Just a Chatbox 55:16 - Cortex: AI-Powered Features at Robinhood 56:54 - Tokenization and the Future of Asset Management 57:44 - Crowdsourced, Tokenized Hedge Funds 58:48 - Portability of Tokenized Assets 59:39 - Blockchain as the New Rails of Finance 01:00:09 - The Trump Token and Capital Formation 01:01:00 - Capital Access Unlocks Innovation 01:01:49 - Why Crypto Needs Regulatory Clarity 01:03:17 - From Meme Coins to Real Assets 01:04:17 - Crypto's Path to $100 Trillion? 01:05:15 - The Financial System Will Run on Blockchains 01:06:00 - Platform Layer vs Application Layer Wealth 01:06:29 - AI Raises Money and Launches Tokens 01:07:39 - AIs Creating Software and Capital Formation 01:08:00 - Final Thoughts: A Wild Future Ahead 01:08:20 - When Will Vlad Buy a CryptoPunk? 01:08:51 - Wrapping Up: AI, Crypto, and the Road Ahead

Raoul Pal

172,640 просмотров • 1 год назад

Is there a Christian revival going on in America? Cliffe Knechtle would know. He’s been preaching on college campuses for 45 years. (0:00) Moral Relativism Is Running Rampant (8:23) The Tragedy of Transgenderism (17:54) Protestantism vs. Catholicism vs. Orthodoxy (25:12) Cliffe’s Greatest Challenge (28:12) The Importance of Self-Discipline (29:43) Cliffe’s Biggest Debates (34:54) Why Is the Old Testament So Violent? (44:49) The Emotional Fragility of Young America (48:44) Why Secularists Hate Christianity (53:52) The Demonic Forces at Work In the World (56:05) Judas, Pharaoh, and Free Will (1:03:03) Are People Inherently Good? (1:07:28) Cliffe’s Thoughts on Gay Marriage (1:11:34) Cliffe’s Response to Abortion (1:19:15) The Dangers of Self-Righteousness (1:27:21) Who Really Are God’s Chosen People? (1:34:18) The Continuous Rise of Christian Persecution (1:37:58) Is Cliffe Ever Worried for His Safety? (1:38:49) More and More People Are Converting to Christianity (1:39:48) Is Divorce a Sin? (1:41:36) Drugs and Alcoholism (1:45:28) Is Cliffe Hopeful for America’s Future? Includes Paid Partnerships.

Is there a Christian revival going on in America? Cliffe Knechtle would know. He’s been preaching on college campuses for 45 years. (0:00) Moral Relativism Is Running Rampant (8:23) The Tragedy of Transgenderism (17:54) Protestantism vs. Catholicism vs. Orthodoxy (25:12) Cliffe’s Greatest Challenge (28:12) The Importance of Self-Discipline (29:43) Cliffe’s Biggest Debates (34:54) Why Is the Old Testament So Violent? (44:49) The Emotional Fragility of Young America (48:44) Why Secularists Hate Christianity (53:52) The Demonic Forces at Work In the World (56:05) Judas, Pharaoh, and Free Will (1:03:03) Are People Inherently Good? (1:07:28) Cliffe’s Thoughts on Gay Marriage (1:11:34) Cliffe’s Response to Abortion (1:19:15) The Dangers of Self-Righteousness (1:27:21) Who Really Are God’s Chosen People? (1:34:18) The Continuous Rise of Christian Persecution (1:37:58) Is Cliffe Ever Worried for His Safety? (1:38:49) More and More People Are Converting to Christianity (1:39:48) Is Divorce a Sin? (1:41:36) Drugs and Alcoholism (1:45:28) Is Cliffe Hopeful for America’s Future? Includes Paid Partnerships.

Tucker Carlson

2,725,926 просмотров • 1 год назад